Cargando…

Stratification of patients with unclassified pain in the FabryScan database

PURPOSE: Fabry disease belongs to lysosomal storage disorders and can be successfully treated today. On the contrary, the correct diagnostic classification of its symptoms can be challenging and most patients suffer from pain for years, until they are diagnosed correctly. The aim of this project was...

Descripción completa

Detalles Bibliográficos
Autores principales: Forstenpointner, Julia, Moeller, Paul, Sendel, Manon, Reimer, Maren, Hüllemann, Philipp, Baron, Ralf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6662527/
https://www.ncbi.nlm.nih.gov/pubmed/31413620
http://dx.doi.org/10.2147/JPR.S206223
_version_ 1783439673295634432
author Forstenpointner, Julia
Moeller, Paul
Sendel, Manon
Reimer, Maren
Hüllemann, Philipp
Baron, Ralf
author_facet Forstenpointner, Julia
Moeller, Paul
Sendel, Manon
Reimer, Maren
Hüllemann, Philipp
Baron, Ralf
author_sort Forstenpointner, Julia
collection PubMed
description PURPOSE: Fabry disease belongs to lysosomal storage disorders and can be successfully treated today. On the contrary, the correct diagnostic classification of its symptoms can be challenging and most patients suffer from pain for years, until they are diagnosed correctly. The aim of this project was to characterize patients with unclassified extremity pain and to present a simple algorithm for a retrospective stratification approach. PATIENTS AND METHODS: The FabryScan includes a bedside-test and a questionnaire, consisting of 10 symptom-orientated and anamnestic questions. For the stratification of patients according to the likelihood for Fabry disease two different approaches were conducted. First, a prospective subgrouping based on the previously invented FabryScan evaluation system was conducted. The second retrospective approach consisted of a factor analysis and a subsequent two-way cluster analysis. Further on, 4 patients diagnosed with Fabry disease were stratified according to both approaches. RESULTS: In total, 183 completed datasets were included in the statistical analysis. The first approach prospectively classified patients into 3 subgroups (n=40 [likely], n=96 [possible], n=47 [unlikely]) according to the FabryScan evaluation system. The second approach retrospectively stratified patients into 3 subgroups (n=47 [cluster 1], n=95 [cluster 2], n=41 [cluster 3]). Finally, the Fabry patients were sorted to the subgroups, indicative for the highest possibility of Fabry disease in both stratification approaches A and B. CONCLUSION: Both stratification approaches sorted patients with confirmed Fabry disease to the subgroups, indicative for the highest likelihood for Fabry. These results indicate validity of the initially selected FabryScan outcome parameters.
format Online
Article
Text
id pubmed-6662527
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-66625272019-08-14 Stratification of patients with unclassified pain in the FabryScan database Forstenpointner, Julia Moeller, Paul Sendel, Manon Reimer, Maren Hüllemann, Philipp Baron, Ralf J Pain Res Original Research PURPOSE: Fabry disease belongs to lysosomal storage disorders and can be successfully treated today. On the contrary, the correct diagnostic classification of its symptoms can be challenging and most patients suffer from pain for years, until they are diagnosed correctly. The aim of this project was to characterize patients with unclassified extremity pain and to present a simple algorithm for a retrospective stratification approach. PATIENTS AND METHODS: The FabryScan includes a bedside-test and a questionnaire, consisting of 10 symptom-orientated and anamnestic questions. For the stratification of patients according to the likelihood for Fabry disease two different approaches were conducted. First, a prospective subgrouping based on the previously invented FabryScan evaluation system was conducted. The second retrospective approach consisted of a factor analysis and a subsequent two-way cluster analysis. Further on, 4 patients diagnosed with Fabry disease were stratified according to both approaches. RESULTS: In total, 183 completed datasets were included in the statistical analysis. The first approach prospectively classified patients into 3 subgroups (n=40 [likely], n=96 [possible], n=47 [unlikely]) according to the FabryScan evaluation system. The second approach retrospectively stratified patients into 3 subgroups (n=47 [cluster 1], n=95 [cluster 2], n=41 [cluster 3]). Finally, the Fabry patients were sorted to the subgroups, indicative for the highest possibility of Fabry disease in both stratification approaches A and B. CONCLUSION: Both stratification approaches sorted patients with confirmed Fabry disease to the subgroups, indicative for the highest likelihood for Fabry. These results indicate validity of the initially selected FabryScan outcome parameters. Dove 2019-07-23 /pmc/articles/PMC6662527/ /pubmed/31413620 http://dx.doi.org/10.2147/JPR.S206223 Text en © 2019 Forstenpointner et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Forstenpointner, Julia
Moeller, Paul
Sendel, Manon
Reimer, Maren
Hüllemann, Philipp
Baron, Ralf
Stratification of patients with unclassified pain in the FabryScan database
title Stratification of patients with unclassified pain in the FabryScan database
title_full Stratification of patients with unclassified pain in the FabryScan database
title_fullStr Stratification of patients with unclassified pain in the FabryScan database
title_full_unstemmed Stratification of patients with unclassified pain in the FabryScan database
title_short Stratification of patients with unclassified pain in the FabryScan database
title_sort stratification of patients with unclassified pain in the fabryscan database
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6662527/
https://www.ncbi.nlm.nih.gov/pubmed/31413620
http://dx.doi.org/10.2147/JPR.S206223
work_keys_str_mv AT forstenpointnerjulia stratificationofpatientswithunclassifiedpaininthefabryscandatabase
AT moellerpaul stratificationofpatientswithunclassifiedpaininthefabryscandatabase
AT sendelmanon stratificationofpatientswithunclassifiedpaininthefabryscandatabase
AT reimermaren stratificationofpatientswithunclassifiedpaininthefabryscandatabase
AT hullemannphilipp stratificationofpatientswithunclassifiedpaininthefabryscandatabase
AT baronralf stratificationofpatientswithunclassifiedpaininthefabryscandatabase